A Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) (CHONQUER (CL3-95031-007))

Principal Investigator

Dr Sarah Pratap

Contact us

Email: latephaseoncology@ouh.nhs.uk

IRAS number

1009431